1 | 5009111000001105 | - | - | - | - | [1] 43 43 |
2 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [17] 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 |
3 | Avacopan | [1] Avacopan Avacopan | [1] D11093
D11093
| [1] C5AR1 C5AR1 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬 | [3] 43 43, 44, 222 |
4 | Azathioprine | [1] Azathioprine Azathioprine | [1] D00238
D00238
| - | - | [21] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
5 | BELIMUMAB | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [13] 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 |
6 | Belimumab 10 mg/kg | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 43 43, 46, 49 |
7 | Benlysta | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [5] 43 43, 49, 53, 66, 222 |
8 | Benlysta 400 mg powder for concentrate for solution for infusion | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 43 43, 49 |
9 | Benlysta 400mg polvere per concentrato per soluzione per infusione | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 43 43 |
10 | Blisibimod | [1] Blisibimod Blisibimod | [1] D10311
D10311
| - | - | [5] 43 43, 44, 49, 63, 66 |
11 | CCX168 | - | - | - | - | [5] 43 43, 44, 66, 109, 222 |
12 | CELLCEPT | - | - | - | - | [5] 11 11, 13, 42, 43, 49 |
13 | CellCept (Mycophenolate Mofetil) | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] D00752
D00752
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [2] 42 42, 43 |
14 | Chimeric monoclonal antibody, IgG4 subtype | - | - | - | - | [2] 43 43, 44 |
15 | Corticosteroid | - | - | - | - | [9] 13 13, 42, 43, 44, 45, 66, 96, 97, 222 |
16 | Corticosteroid and azathioprine | [1] Azathioprine Azathioprine | [1] D00238
D00238
| - | - | [4] 42 42, 43, 44, 45 |
17 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 |
18 | Cyclophosphamide, Azathioprine,prednisone,methylprednisolone | [4] Azathioprine Azathioprine, Cyclophosphamide, Methylprednisolone, Prednisone | [5] D00238
D00238
,
D00287
,
D00407
,
D00473
,
D07760
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 |
19 | DELTACORTENE | - | - | - | - | [2] 43 43, 97 |
20 | ENDOXAN | - | - | - | - | [7] 13 13, 28, 43, 44, 85, 96, 222 |
21 | ENDOXAN BAXTER | - | - | - | - | [3] 13 13, 43, 96 |
22 | Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 43, 45 |
23 | GALEN® tablet | - | - | - | - | [2] 43 43, 44 |
24 | Glucocorticoid (GC) | - | - | - | - | [2] 43 43, 44 |
25 | Glucocorticoids | - | - | - | - | [8] 40 40, 41, 43, 44, 60, 62, 75, 300 |
26 | Glucocorticoids (GC) | - | - | - | - | [2] 43 43, 44 |
27 | Glucocorticoids - Reduced Dose | - | - | - | - | [2] 43 43, 44 |
28 | Glucocorticoids - Standard Dose | - | - | - | - | [2] 43 43, 44 |
29 | Glucocorticoids [Reduced Dose] | - | - | - | - | [2] 43 43, 44 |
30 | Glucocorticoids [Standard Dose] | - | - | - | - | [2] 43 43, 44 |
31 | Human normal immunoglobulin | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [9] 11 11, 13, 14, 43, 45, 50, 51, 63, 65 |
32 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
| - | - | [27] 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
33 | IFX-1 | [1] Vilobelimab Vilobelimab | [1] D11838
D11838
| [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 43 43, 44, 269 |
34 | Infliximab | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [26] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
35 | Intravenous immunoglobulins (human immunoglobulins G) | - | - | - | - | [1] 43 43 |
36 | Intravenous methyl prednisolone | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 |
37 | MabThera | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [22] 11 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 |
38 | Mabthera® | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [6] 13 13, 35, 43, 44, 46, 93 |
39 | MabThera® 100MG | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 43 43 |
40 | MabThera® 500MG | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 43 43 |
41 | Methotrexate | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [38] 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
42 | Methyl prednisolone | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 43 43, 49, 96 |
43 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [1] D00407
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [46] 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
44 | Methylprednisolone (or other glucocorticoid) | [1] Methylprednisolone Methylprednisolone | [1] D00407
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 |
45 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
46 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] D00752
D00752
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
47 | Mycophenolate mofetil,methotrexate | [3] Methotrexate Methotrexate, Mycophenolate mofetil, Mycophenolic acid | [3] D00142
D00142
,
D00752
,
D05096
| [4] DHFR DHFR, DHFR2, IMPDH1, IMPDH2 💬 | [8] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, Nucleotide metabolism, One carbon pool by folate, Purine metabolism 💬 | [3] 42 42, 43, 45 |
48 | Mycophenolic acid | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [8] 11 11, 43, 49, 51, 60, 66, 96, 222 |
49 | Naltrexone | [1] Naltrexone Naltrexone | [1] D05113
D05113
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [12] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 |
50 | NALTREXONE HYDROCHLORIDE | [1] Naltrexone Naltrexone | [1] D05113
D05113
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 10 10, 40, 41, 42, 43, 44, 45, 96 |
51 | Obinutuzumab | [1] Obinutuzumab Obinutuzumab | [1] D09321
D09321
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [4] 43 43, 44, 49, 222 |
52 | Pednisone | - | - | - | - | [2] 43 43, 44 |
53 | Placebo (physiological saline) | - | - | - | - | [2] 43 43, 45 |
54 | Plaquenil - Hydroxychloroquine 200mg Film coated tablets | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
| - | - | [3] 43 43, 44, 45 |
55 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [42] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
56 | Prednison acis® 20 mg | - | - | - | - | [2] 43 43, 44 |
57 | Prednison acis® 5 mg | - | - | - | - | [2] 43 43, 44 |
58 | Prednison acis¿ 20 mg | - | - | - | - | [2] 43 43, 44 |
59 | Prednison acis¿ 5 mg | - | - | - | - | [2] 43 43, 44 |
60 | Prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 |
61 | Prednisone (and methylprednisolone) | [2] Methylprednisolone Methylprednisolone, Prednisone | [2] D00407
D00407
,
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 |
62 | PredniSONE Tablets, USP | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 41 41, 43, 44 |
63 | Prednisone, methylprednisolone,cyclophosphamides | [2] Methylprednisolone Methylprednisolone, Prednisone | [2] D00407
D00407
,
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 |
64 | Remission induction therapy | - | - | - | - | [2] 43 43, 44 |
65 | RITUXIMAB | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [48] 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
66 | Rituximab (Arm A) | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 43 43, 44 |
67 | Rituximab (Arm B) | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 43 43, 44 |
68 | RIXATHON 500mg | - | - | - | - | [1] 43 43 |
69 | RO0452294/V01 | - | - | - | - | [2] 43 43, 44 |
70 | RO0452294/V02 | - | - | - | - | [3] 35 35, 43, 44 |
71 | Ro106-1443 | - | - | - | - | [1] 43 43 |
72 | Sendoxan | - | - | - | - | [2] 13 13, 43 |
73 | Tocilizumab | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [21] 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 |
74 | Vilobelimab | [1] Vilobelimab Vilobelimab | [1] D11838
D11838
| [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2] 43 43, 44 |
75 | Vitamin D | [1] Vitamin D Vitamin D | - | - | - | [20] 13 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 298, 299 |